Patents Assigned to Takara
  • Patent number: 11046939
    Abstract: The present invention relates to a Thermus aquaticus (Taq) polymerase having a strand displacement activity in which an amino acid residue in a template DNA binding site of the DNA polymerase is substituted with an amino acid to increase a total charge in the site, a nucleic acid encoding the polymerase, a vector containing the nucleic acid, a transformant containing the vector containing the nucleic acid or the nucleic acid, a method for producing the polymerase, a method for amplifying nucleic acids utilizing the polymerase, and a kit containing the polymerase. According to the present invention, a DNA polymerase having a high thermostability, capable of efficiently replicating a long-strand of a template DNA, and having a strong strand displacement activity is provided.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: June 29, 2021
    Assignees: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, TAKARA BIO INC.
    Inventors: Yoshizumi Ishino, Sonoko Ishino, Takeshi Yamagami, Takashi Uemori, Nariaki Takatsu
  • Publication number: 20210189332
    Abstract: Directed differentiation and maturation of mammalian hepatocytes, such as human hepatocytes. The hepatocyte obtained show a phenotype which is more similar to that of primary hepatocytes than previously shown. In particular, exposure of mammalian hepatocytes, such as human hepatocytes, to at least one maturation factor selected from the group consisting of Src kinase inhibitors, vitamin D including precursors, metabolites and analogs thereof, hypoxia inducing compounds, sphingosine and sphingosine derivatives, activators of peroxisome proliferator-activated receptors (PPARs), platelet-activating factor (PAF), PKC inhibitors, and combinations thereof.
    Type: Application
    Filed: March 9, 2021
    Publication date: June 24, 2021
    Applicant: Takara Bio Europe AB
    Inventor: Barbara KÜPPERS-MUNTHER
  • Patent number: 11028131
    Abstract: The present invention provides: a mutant of adeno-associated virus (AAV) capsid protein, which contains at least one amino acid substitution in PLA2 domain when compared with the amino acid sequence for wild-type AAV capsid protein; a nucleic acid encoding the mutant; a cell containing the nucleic acid; a method for producing a recombinant AAV particle, comprising a step of culturing the cell to produce the recombinant AAV particle; a recombinant AAV particle containing the mutant; a composition containing the recombinant AAV particle; and a method for transferring a gene into a target cell, comprising a step of bringing the recombinant AAV particle into contact with the target cell.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: June 8, 2021
    Assignees: NIPPON MEDICAL SCHOOL FOUNDATION, NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY, TAKARA BIO INC.
    Inventors: Takashi Okada, Hironori Okada, Hiromi Kinoh, Tatsuji Enoki, Toshikazu Nishie, Junichi Mineno
  • Publication number: 20210164018
    Abstract: The present invention pertains to: an oligonucleotide preservation method; and a kit comprising an oligonucleotide. The present invention provides a method for stably preserving an oligonucleotide-containing solution by adding a nucleic acid-binding protein to said oligonucleotide-containing solution in advance.
    Type: Application
    Filed: June 6, 2018
    Publication date: June 3, 2021
    Applicant: TAKARA BIO INC.
    Inventors: Miwa AKITOMO, Takashi UEMORI
  • Patent number: 11001882
    Abstract: Provided are methods of producing a product nucleic acid. The methods include combining a template deoxyribonucleic acid (DNA), a polymerase, a template switch oligonucleotide, and dNTPs into a reaction mixture. The components are combined into the reaction mixture under conditions sufficient to produce a product nucleic acid that includes the template DNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: May 11, 2021
    Assignee: Takara Bio USA, Inc.
    Inventors: Craig Betts, Andrew Alan Farmer, Nathalie Bolduc
  • Patent number: 10988796
    Abstract: Provided are methods of depleting a target nucleic acid from an initial collection of nucleic acids. Aspects of the methods include contacting the initial collection with a nucleic acid guided nuclease specific for the target nucleic acid in a manner sufficient to deplete the target nucleic acid from the initial collection. Depending on a given application, depletion of a target nucleic acid may vary, e.g., where depleting may include cleaving a target nucleic acid in, or selectively separating a target nucleic acid from, the initial collection of nucleic acids. Also provided are compositions and kits for practicing embodiments of the methods.
    Type: Grant
    Filed: October 8, 2018
    Date of Patent: April 27, 2021
    Assignee: Takara Bio USA, Inc.
    Inventors: Andrew Alan Farmer, Craig Betts, Nathalie Bolduc
  • Patent number: 10975415
    Abstract: A polypeptide having a mismatch endonuclease activity of recognizing a mismatch and cleaving the mismatch; a mismatch-specific cleavage reaction using the polypeptide; a method for removing an error in a nucleic acid amplification reaction utilizing the polypeptide; a method for inhibiting the amplification of a nucleic acid comprising a specific nucleotide sequence during a nucleic acid amplification reaction; and a method for detecting a nucleic acid having a single-nucleotide polymorphism mutation utilizing the inhibition method.
    Type: Grant
    Filed: September 9, 2015
    Date of Patent: April 13, 2021
    Assignees: TAKARA BIO INC., KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, EDUCATIONAL CORPORATION KANSAI BUNRI SOUGOUGAKUEN
    Inventors: Takashi Uemori, Yoshizumi Ishino, Takehiro Sagara, Sonoko Ishino, Takeshi Yamagami, Tsuyoshi Shirai
  • Patent number: 10961529
    Abstract: Methods of barcoding nucleic acids, such as genomic DNA, are provided herein. In some embodiments, a fragment of genomic DNA may comprise a first and a second barcode.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: March 30, 2021
    Assignee: Takara Bio USA, Inc.
    Inventors: Takao Kurihara, Emmanuel Kamberov, Tim Tesmer, John Langmore
  • Patent number: 10954510
    Abstract: Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template ribonucleic acid (RNA), a template switch oligonucleotide including a 3? hybridization domain and a sequencing platform adapter construct, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template RNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: March 23, 2021
    Assignee: Takara Bio USA, Inc.
    Inventors: Craig Betts, Steve Oh, George G. Jokhadze, Nathalie Bolduc
  • Patent number: 10941397
    Abstract: Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template ribonucleic acid (RNA), a template switch oligonucleotide including a 3? hybridization domain and a sequencing platform adapter construct, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template RNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: March 9, 2021
    Assignee: Takara Bio USA, Inc.
    Inventors: Craig Betts, Steve Oh, George Jokhadze, Nathalie Bolduc
  • Publication number: 20210062141
    Abstract: In the present invention, lymphocytes are efficiently grown by culturing lymphocytes in the presence of a novel recombinant fibronectin fragment.
    Type: Application
    Filed: January 24, 2019
    Publication date: March 4, 2021
    Applicant: TAKARA BIO INC.
    Inventors: Tomomi OTSUJI, Yuka HIRASE, Asako HATSUYAMA, Sachiko OKAMOTO, Tatsuji ENOKI, Junichi MINENO
  • Patent number: 10913932
    Abstract: The present invention relates to directed differentiation and maturation of mammalian hepatocytes, such as human hepatocytes. The hepatocyte obtained in accordance with the present invention show a phenotype which is more similar to that of primary hepatocytes than previously shown. In particular, the present invention relates to exposure of mammalian hepatocytes, such as human hepatocytes, to at least one maturation factor selected from the group consisting of Src kinase inhibitors, vitamin D including precursors, metabolites and analogs thereof, hypoxia inducing compounds, sphingosine and sphingosine derivatives, activators of peroxisome proliferator-activated receptors (PPARs), platelet-activating factor (PAF), PKC inhibitors, and combinations thereof.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: February 9, 2021
    Assignee: TAKARA BIO EUROPE AB
    Inventor: Barbara Kuppers-Munther
  • Publication number: 20210032593
    Abstract: Directed differentiation and maturation of mammalian hepatocytes, such as human hepatocytes. The hepatocyte obtained show a phenotype which is more similar to that of primary hepatocytes than previously shown. In particular, exposure of mammalian hepatocytes, such as human hepatocytes, to at least one maturation factor selected from the group consisting of Src kinase inhibitors, vitamin D including precursors, metabolites and analogs thereof, hypoxia inducing compounds, sphingosine and sphingosine derivatives, activators of peroxisome proliferator-activated receptors (PPARs), platelet-activating factor (PAF), PKC inhibitors, and combinations thereof.
    Type: Application
    Filed: October 9, 2020
    Publication date: February 4, 2021
    Applicant: Takara Bio Europe AB
    Inventor: Barbara KÜPPERS-MUNTHER
  • Patent number: 10870848
    Abstract: Methods of preparing a next generation sequencing (NGS) library from a ribonucleic acid (RNA) sample are provided. Aspects of the methods include combining the RNA sample with a first strand cDNA primer and a template switch oligo-nucleotide under first strand cDNA synthesis conditions, where one of the first strand cDNA primer and the template switch oligo-nucleotide includes a first post-tagmentation amplification primer binding domain. The resultant product is subjected to amplification conditions sufficient to produce a double stranded cDNA, which is then tagmented with a transposome that includes a second post-tagmentation amplification primer binding domain. The tagmented sample is then subjected to amplification conditions using first and second post-tagmentation amplification primers that include sequencing platform adapter constructs to produce a NGS library. Aspects of the invention further include compositions produced by the methods and kits that find use in practicing the methods.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: December 22, 2020
    Assignee: Takara Bio USA, Inc.
    Inventors: Cynthia Chang, Magnolia Bostick
  • Patent number: 10837049
    Abstract: The present invention regards a variety of methods and compositions for whole genome amplification and whole transcriptome amplification. In a particular aspect of the present invention, there is a method of amplifying a genome comprising a library generation step followed by a library amplification step. In specific embodiments, the library generating step utilizes specific primer mixtures and a DNA polymerase, wherein the specific primer mixtures are designed to eliminate ability to self-hybridize and/or hybridize to other primers within a mixture but efficiently and frequently prime nucleic acid templates.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: November 17, 2020
    Assignee: Takara Bio USA, Inc.
    Inventors: Emmanuel Kamberov, Tong Sun, Eric Bruening, Jonathon H. Pinter, Irina Sleptsova, Takao Kurihara, Vladimir L. Makarov
  • Patent number: 10822392
    Abstract: Disclosed herein are chimeric antigen receptors (CARs) comprising an intracellular segment comprising an interleukin receptor chain, a JAK-binding motif, a Signal Transducer and Activator of Transcription (STAT) 5 association motif and/or a CD3? intracellular signaling domain comprising an exogenous STAT3 association motif, as well as cells and 5 compositions comprising said CARs and uses thereof.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: November 3, 2020
    Assignees: University Health Network, Takara Bio Inc.
    Inventors: Shinya Tanaka, Naoto Hirano, Yuki Kagoya
  • Publication number: 20200337930
    Abstract: A moving unit includes a housing, a rotary unit to which a rod part is attached, a spring that generates a torque when the rod part is tilted down or tilted up about a rotation axis on the side on which a base portion of the rod part is located, and a torque adjustment unit that is capable of adjusting a torque by deforming the spring. The torque adjustment unit includes a spring deforming portion that deforms the spring in a direction in which the spring is wound up and a spring fixing portion that keeps a torque constant by coming into contact with the spring deforming portion and fixing the spring deforming portion in place.
    Type: Application
    Filed: November 17, 2017
    Publication date: October 29, 2020
    Applicant: TAKARA BELMONT CORPORATION
    Inventors: Koji NAKAJIMA, Hiroyuki TERAYAMA
  • Publication number: 20200323722
    Abstract: An instrument hose support device includes a rod that supports an instrument hose at a position higher than an instrument that is held by a holder, a pulley support portion that is supported by a distal end of the rod, a pulley that is supported by the pulley support portion and over which the instrument hose is looped. The distal end has a groove in which a taper is formed. A first member of the pulley support portion has a shaft protrusion, and a gap is formed between the shaft protrusion and the groove. The gap serves as the range of motion of the pulley support portion, and the pulley support portion follows the movement of the instrument hose and, relative to the rod, swings freely toward the front and the back and toward the sides and rotates freely with a movable axis (X) as an axis.
    Type: Application
    Filed: November 17, 2017
    Publication date: October 15, 2020
    Applicant: TAKARA BELMONT CORPORATION
    Inventors: Hiroyuki TERAYAMA, Koji NAKAJIMA
  • Patent number: 10793828
    Abstract: Protein enriched micro-vesicles and methods of making and using the same are provided. Aspects of the methods include maintaining a cell having a membrane-associated protein comprising a first dimerization domain and a target protein having a second dimerization domain under conditions sufficient to produce a micro-vesicle from the cell, wherein the micro-vesicle includes the target protein. Also provided are cells, reagents and kits that find use in making the micro-vesicles, as well as methods of using the micro-vesicles, e.g., in research and therapeutic applications.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: October 6, 2020
    Assignee: Takara Bio USA, Inc.
    Inventors: Michael Haugwitz, Thomas Patrick Quinn, Andrew Alan Farmer, Montserrat Morell Fernández
  • Patent number: 10781443
    Abstract: Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template ribonucleic acid (RNA), a template switch oligonucleotide including a 3? hybridization domain and a sequencing platform adapter construct, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template RNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: September 22, 2020
    Assignee: Takara Bio USA, Inc.
    Inventors: Craig Betts, Steve Oh, George G. Jokhadze, Nathalie Bolduc